Effects of renal insufficiency and hemodialysis on the pharmacokinetics of rofecoxib.

American journal of therapeutics

Volumn 10, Issue 4, 2003, Pages 252-258

  Gottesdiener, Keith ^a   Agrawal, Nancy ^a   Porras, Arturo ^a   Wong, Peggy ^a   Rogers, J Douglas ^a   Gertz, Barry J ^a   Redfern, Jan S ^a   Marbury, Thomas ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LACTONE; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SULFONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; FEMALE; HALF LIFE TIME; HUMAN; MALE; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AREA UNDER CURVE; CREATININE; CYCLOOXYGENASE INHIBITORS; FEMALE; HALF-LIFE; HUMANS; KIDNEY FAILURE, CHRONIC; LACTONES; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RENAL DIALYSIS; SULFONES;

EID: 0142151437     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200307000-00004     Document Type: Article

References (0)